BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pascreau T, Tcherakian C, Zuber B, Farfour E, Vasse M, Lassalle P. A high blood endocan profile during COVID-19 distinguishes moderate from severe acute respiratory distress syndrome. Crit Care 2021;25:166. [PMID: 33957951 DOI: 10.1186/s13054-021-03589-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Levy C, Dognon N, Normandin S, Duburcq T, Gaudet A, Parmentier-decrucq E, Poissy J, Dubucquoi S, Boddaert P, Caplan M, Goutay J, Durand A, Graffin B, Gaudel M, Detollenaere C, Gueguen I, Ceunebroek MV, Tortuyaux R, Saura O, Kalioubie AE, Favory R, Girardie P, Houard M, Jaillette E, Jourdain M, Ledoux G, Mathieu D, Moreau AS, Nseir S, Onimus T, Preau S, Robriquet L, Rouze A, Six S, Soquet J, Loobuyck V, Mugnier A, Vincentelli A. Assessment of plasma endocan for the prediction of mortality in COVID-19 patients undergoing veno-venous ECMO: A pilot study. Medicina Intensiva (English Edition) 2022. [DOI: 10.1016/j.medine.2022.04.018] [Reference Citation Analysis]
2 Chenevier-gobeaux C, Ducastel M, Meritet J, Ballaa Y, Chapuis N, Pene F, Carlier N, Roche N, Szwebel T, Terrier B, Borderie D. Plasma Endocan as a Biomarker of Thrombotic Events in COVID-19 Patients. JCM 2022;11:5560. [DOI: 10.3390/jcm11195560] [Reference Citation Analysis]
3 Reikvam H, Hatfield KJ, Wendelbo Ø, Lindås R, Lassalle P, Bruserud Ø. Endocan in Acute Leukemia: Current Knowledge and Future Perspectives. Biomolecules 2022;12:492. [DOI: 10.3390/biom12040492] [Reference Citation Analysis]
4 Honore PM, Redant S, Preseau T, Cismas BV, Kaefer K, Barreto Gutierrez L, Anane S, Attou R, Gallerani A, De Bels D. Is endocan correlated to ARDS severity or an epiphenomenon of thrombo-embolic disease in COVID. Crit Care 2021;25:425. [PMID: 34906200 DOI: 10.1186/s13054-021-03850-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Guzel D, Kalkan EA, Eren F, Zengin O, Erel O, Sahiner ES, Inan O, Ates I. Can Serum Endocan Levels be Used as an Early Prognostic Marker for Endothelial Dysfunction in COVID-19? Angiology 2021;:33197211050446. [PMID: 34663109 DOI: 10.1177/00033197211050446] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]